Sunrest Lifescience LTD

Sunrest Lifescience Ltd (SUNREST) is a micro-cap Healthcare company valued at ₹16 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Sunrest Lifescience Ltd last traded at ₹37, sharply up 9.79% on the day.

Recent developments

On 2026-06-30, promoter holding was recorded at 53.50%, showing no significant change in ownership. The company has not paid dividends despite reporting profits, which may indicate reinvestment in the business. High debtors of 167 days suggest potential liquidity challenges.

Financial performance

The company's business is improving, with annual revenue rising 112.0% and net profit jumping 296.0% year-over-year. The latest quarter saw revenue grow 10.2% compared to the same quarter a year earlier, while net profit surged 225.2%, driven by stronger margins and improved profitability.

Valuation multiples

The stock trades at 3.9 times earnings, a discount to the Healthcare median of 32.0, 0.90 times book value.

Things to watch

The company has not paid dividends despite repeated profits, which could signal reinvestment rather than shareholder returns. High debtors of 167 days indicate potential liquidity issues. The stock is 26.9% below its 52-week high, reflecting a pullback from recent levels.

Where it stands

Sunrest Lifescience Ltd has shown strong growth in both revenue and net profit over the past year and quarter, with margins improving significantly. The company's high debtors and lack of dividend payouts highlight operational and liquidity risks. The stock is currently 26.9% below its 52-week high.

Summarised by DocStoX's model on 2026-09-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.